Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 6 Sponsors

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

Chamber: House
Introduced: Aug 13, 2025
Last action: May 4, 2026 — PRINT NUMBER 9010B
Session: 2025-2026
Momentum: 53 · Moderate

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum +1 53/100 from the pace of recorded action
Time since last action -22 165 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.